Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
205.30B
Market cap205.30B
Price-Earnings ratio
10.74
Price-Earnings ratio10.74
Dividend yield
2.69%
Dividend yield2.69%
Average volume
21.63M
Average volume21.63M
High today
$46.15
High today$46.15
Low today
$45.19
Low today$45.19
Open price
$45.97
Open price$45.97
Volume
6.89M
Volume6.89M
52 Week high
$81.44
52 Week high$81.44
52 Week low
$35.12
52 Week low$35.12

NVO News

The Motley Fool 2h
Scholar Rock Q1 2026 Earnings Transcript

Image source: The Motley Fool. Thursday, May 7, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer — David Hallal President — Akshay Vaishnaw Chie...

Scholar Rock Q1 2026 Earnings Transcript
TipRanks 2h
Novo Nordisk Sees 40% Spike in India April Sales Despite Generic GLP-1 Rivalry

Danish drugmaker Novo Nordisk (NVO) saw a 40% jump in the sales of its diabetes and weight-loss drugs in April in India, despite intense competition from generi...

TipRanks 20h
Mixed options sentiment in Novo Nordisk with shareslittle changed

Mixed options sentiment in Novo Nordisk (NVO), with shares up 4c, or 0.1%, near $45.80. Options volume relatively light with 69k contracts traded and calls lead...

Analyst ratings

60%

of 35 ratings
Buy
31.4%
Hold
60%
Sell
8.6%

More NVO News

Simply Wall St 21h
Assessing Omeros Valuation After Recent Share Price Rebound And Novo Nordisk Deal Prospects

Advertisement What recent performance signals for Omeros (OMER) Without a single defining headline driving trading, Omeros (OMER) has still drawn attention af...

Assessing Omeros Valuation After Recent Share Price Rebound And Novo Nordisk Deal Prospects
Nasdaq 23h
Forget Eli Lilly: These 2 Stocks Have More Upside

Key Points Investors have placed a high valuation on Eli Lilly because they believe GLP-1 drugs represent a massive opportunity. Eli Lilly is growing quickly...

Forget Eli Lilly: These 2 Stocks Have More Upside
TipRanks 1d
Novo and Lilly Stocks Jump as Weight-Loss Pills Reveal Monster Market Potential

Shares of Novo Nordisk (NVO) and Eli Lilly & Co. (LLY), two of the world’s largest drugmakers, rose slightly on Wednesday after data showed strong demand for th...

TipRanks 1d
Amazon.com expands access to Ozempic pill via same-day delivery

Amazon Pharmacy (AMZN) is expanding access to Novo Nordisk’s (NVO) Ozempic pill, the only FDA-approved oral GLP-1 medication to treat type 2 diabetes. Amazon Ph...

TipRanks 1d
Eli Lilly Raises Bet to $21B as Obesity Pill War with Novo Nordisk Intensifies

U.S. pharma giant Eli Lilly (LLY) has pumped another $4.5 billion investment into its manufacturing facilities in Indiana, a key anchor of its domestic manufact...

The Motley Fool 1d
My Top Obesity Stock to Buy and Hold

If you're looking for exposure to the anti-obesity drug market, you essentially have just two choices: You can chase smaller biotech stocks that might develop t...

My Top Obesity Stock to Buy and Hold
CNBC 2d
Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals

Key Points Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before. Analysts have questioned whether Novo c...

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.